Literature DB >> 16177210

Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro.

Jenni Hakkarainen1, Marko Toivanen, Anni Leinonen, Lars Frängsmyr, Nicklas Strömberg, Seppo Lapinjoki, Xavier Nassif, Carina Tikkanen-Kaukanen.   

Abstract

Milk oligosaccharides have been shown to interfere with adhesion of many pathogens to host mucosal surfaces. Characterization of the adhesion mechanisms of the bacteria to host cell surface is needed to develop novel functional food, infant formulas, and anti-infective drugs. Adhesion of Neisseria meningitidis, a human specific pathogen causing meningitis and septicemia, is not completely understood but is mediated by type IV pili. Here, we developed a microtiter well pili binding assay to investigate the binding activities of N. meningitidis isolated type IV pili to different glycoproteins. Pili binding activities to bovine thyroglobulin and human salivary agglutinin but not to chicken ovalbumin were present. Inhibition of these binding activities was demonstrated by fractionated human or bovine milk oligosaccharides. The binding of neisserial pili to bovine thyroglobulin was most effective and was clearly inhibited by human milk neutral or bovine milk acidic oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177210     DOI: 10.1093/jn/135.10.2445

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  16 in total

1.  Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures.

Authors:  Danielle L Aldredge; Maria R Geronimo; Serenus Hua; Charles C Nwosu; Carlito B Lebrilla; Daniela Barile
Journal:  Glycobiology       Date:  2013-02-22       Impact factor: 4.313

Review 2.  Antibiofilm polysaccharides.

Authors:  Olaya Rendueles; Jeffrey B Kaplan; Jean-Marc Ghigo
Journal:  Environ Microbiol       Date:  2012-06-26       Impact factor: 5.491

Review 3.  Bovine milk as a source of functional oligosaccharides for improving human health.

Authors:  Angela M Zivkovic; Daniela Barile
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

Review 4.  Novel strategies to combat bacterial virulence.

Authors:  Susan V Lynch; Jeanine P Wiener-Kronish
Journal:  Curr Opin Crit Care       Date:  2008-10       Impact factor: 3.687

Review 5.  Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications.

Authors:  Daniel Garrido; David C Dallas; David A Mills
Journal:  Microbiology       Date:  2013-03-04       Impact factor: 2.777

6.  Production of functional mimics of human milk oligosaccharides by enzymatic glycosylation of bovine milk oligosaccharides.

Authors:  Valerie Weinborn; Yanhong Li; Ishita M Shah; Hai Yu; David C Dallas; J Bruce German; David A Mills; Xi Chen; Daniela Barile
Journal:  Int Dairy J       Date:  2019-11-13       Impact factor: 3.032

Review 7.  Milk proteins, peptides, and oligosaccharides: effects against the 21st century disorders.

Authors:  Chia-Chien Hsieh; Blanca Hernández-Ledesma; Samuel Fernández-Tomé; Valerie Weinborn; Daniela Barile; Juliana María Leite Nobrega de Moura Bell
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

8.  Novel anti-infective potential of salvianolic acid B against human serious pathogen Neisseria meningitidis.

Authors:  Sanna Huttunen; Marko Toivanen; Chenghai Liu; Carina Tikkanen-Kaukanen
Journal:  BMC Res Notes       Date:  2016-01-13

9.  Coupling Mass Spectrometry-Based "Omic" Sciences with Bioguided Processing to Unravel Milk's Hidden Bioactivities.

Authors:  David C Dallas; Hyeyoung Lee; Annabelle Le Parc; Juliana Maria Leite Nobrega de Moura Bell; Daniela Barile
Journal:  J Adv Dairy Res       Date:  2013-07-24

10.  Temporal Change of the Content of 10 Oligosaccharides in the Milk of Chinese Urban Mothers.

Authors:  Sean Austin; Carlos A De Castro; Thierry Bénet; Yangfeng Hou; Henan Sun; Sagar K Thakkar; Gerard Vinyes-Pares; Yumei Zhang; Peiyu Wang
Journal:  Nutrients       Date:  2016-06-08       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.